Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial

被引：0
|
作者：
Javier Cortés
Hope S. Rugo
Ahmad Awada
Chris Twelves
Edith A. Perez
Seock–Ah Im
Patricia Gómez-Pardo
Lee S. Schwartzberg
Veronique Diéras
Denise A. Yardley
David A. Potter
Audrey Mailliez
Alvaro Moreno-Aspitia
Jin-Seok Ahn
Carol Zhao
Ute Hoch
Mary Tagliaferri
Alison L. Hannah
Joyce O’Shaughnessy
机构：
[1] Ramon y Cajal University Hospital,Medical Oncology Clinic
[2] Madrid,Department of Medicine, Masonic Cancer Center
[3] Spain and Vall d’Hebron Institute of Oncology,Department of Medicine, Samsung Medical Center
[4] University of California,undefined
[5] Jules Bordet Institute,undefined
[6] Leeds Institute of Cancer and Pathology and St James’s University Hospital,undefined
[7] Mayo Clinic,undefined
[8] Seoul National University Hospital,undefined
[9] Cancer Research Institute,undefined
[10] Seoul National University College of Medicine,undefined
[11] Vall d’Hebron Institute of Oncology,undefined
[12] The West Clinic,undefined
[13] Institut Curie,undefined
[14] Sarah Cannon Research Institute,undefined
[15] University of Minnesota,undefined
[16] Centre Oscar Lambret,undefined
[17] Sungkyunkwan University School of Medicine,undefined
[18] Nektar Therapeutics,undefined
[19] Consultant,undefined
[20] Texas Oncology-Baylor Charles A. Sammons Cancer Center/U.S. Oncology,undefined
来源：
Breast Cancer Research and Treatment | 2017年 / 166卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：327 / 328
页数：1
相关论文
共 50 条
  • [21] Risk factors and survival outcomes in patients with brain metastases from breast cancer
    A. M. Minisini
    S. Moroso
    L. Gerratana
    M. Giangreco
    D. Iacono
    E. Poletto
    M. Guardascione
    C. Fontanella
    G. Fasola
    F. Puglisi
    Clinical & Experimental Metastasis, 2013, 30 : 951 - 956
  • [22] Prediction of very short survival in patients with brain metastases from breast cancer
    Nieder, C.
    Marienhagen, K.
    Thamm, R.
    Astner, S. T.
    Molls, M.
    Norum, J.
    CLINICAL ONCOLOGY, 2008, 20 (05) : 337 - 339
  • [23] First-line bevacizumab plus paclitaxel in Japanese patients with HER2-negative metastatic breast cancer: subgroup results from the randomized Phase III MERiDiAN trial
    Masuda, Norikazu
    Takahashi, Masato
    Nakagami, Kazuhiko
    Okumura, Yasuhiro
    Nakayama, Takahiro
    Sato, Nobuaki
    Kanatani, Kazumitsu
    Tajima, Kosei
    Kashiwaba, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (05) : 385 - 392
  • [24] Randomized Phase III Trial Comparing Gamma Knife and Linac Based (EDGE) Approaches for Brain Metastases Radiosurgery: Results from the Gadget Trial
    Navarria, P.
    Clerici, E.
    Carta, G.
    Attuati, L.
    Picozzi, P.
    Franzese, C.
    D'Agostino, G. R.
    Tomatis, S.
    Mancosu, P.
    Cozzi, L.
    Reggiori, G.
    Scorsetti, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S143 - S144
  • [25] Intravenous ibandronate does not affect time to renal function deterioration in patients with skeletal metastases from breast cancer: phase III trial results
    Body, J. J.
    Diel, I. J.
    Tripathy, D.
    Bergstrom, B.
    EUROPEAN JOURNAL OF CANCER CARE, 2006, 15 (03) : 299 - 302
  • [26] Final overall survival and updated biomarker analysis results from the randomized phase III ICOGEN trial.
    Sun, Yan
    Shi, Yuankai
    Zhang, Li
    Liu, Xiaoqing
    Zhou, Caicun
    Zhang, Li
    Wang, Dong
    Li, Qiang
    Zhang, Shucai
    Qin, Shukui
    Hu, Chunhong
    Zhang, Yiping
    Chen, Jianhua
    Song, Yong
    Feng, Ji Feng
    Cheng, Ying
    Zhang, Helong
    Wu, Yi Long
    Xu, Nong
    Zhou, Jianying
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [27] Survival outcomes for patients with invasive lobular cancer by MammaPrint: Results from the MINDACT phase III trial
    Metzger Filho, O.
    Cardoso, F.
    Poncet, C.
    Desmedt, C.
    Linn, S.
    Wesseling, J.
    Hilbers, F.
    Delaloge, S.
    Pierga, J. -y.
    Brain, E.
    Vrijaldenhoven, S.
    Neijenhuis, P. A.
    Rutgers, E. J. Th
    Piccart, M.
    van't Veer, L. J.
    Viale, G.
    EUROPEAN JOURNAL OF CANCER, 2025, 217
  • [28] Potential Surrogate Endpoints for Prostate Cancer Survival: Analysis of a Phase III Randomized Trial
    Ray, Michael E.
    Bae, Kyounghwa
    Hussain, Maha H. A.
    Hanks, Gerald E.
    Shipley, William U.
    Sandler, Howard M.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (04) : 228 - 236
  • [29] Exclusion of Patients With Brain Metastases in Published Phase III Clinical Trials for Advanced Breast Cancer
    Sharma, Alisha
    Searle, Karlee
    Hasan, Salwa
    Chan, Stephanie
    Pond, Gregory
    Jerzak, Katarzyna J.
    CLINICAL BREAST CANCER, 2022, 22 (07) : 629 - 633
  • [30] Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer
    Takeshi Suto
    Megumi Ishiguro
    Chikuma Hamada
    Katsuyuki Kunieda
    Hiroyuki Masuko
    Ken Kondo
    Hideyuki Ishida
    Genichi Nishimura
    Kazuaki Sasaki
    Takayuki Morita
    Shoichi Hazama
    Koutarou Maeda
    Hideyuki Mishima
    Hideyuki Ike
    Sotaro Sadahiro
    Kenichi Sugihara
    Masazumi Okajima
    Shigetoyo Saji
    Junichi Sakamoto
    Naohiro Tomita
    International Journal of Clinical Oncology, 2017, 22 : 805 - 806
12345